CBDBuzzz.com
  • Home
  • News
  • Culture
  • Science
  • Health
  • Videos
  • Shop
No Result
View All Result
CBDBuzzz.com
  • Home
  • News
  • Culture
  • Science
  • Health
  • Videos
  • Shop
No Result
View All Result
CBDBuzzz.com
No Result
View All Result

Cannabis firms see jump in insurance costs to protect leaders as investors sue

July 8, 2020
in News
Reading Time: 3 mins read
A A
Cannabis firms see jump in insurance costs to protect leaders as investors sue
400
SHARES
2.4k
VIEWS
ShareShareShareShareShare
FILE PHOTO: Employees sort medical cannabis flowers at Pharmocann, an Israeli medical cannabis company in northern Israel June 24, 2020. Picture taken June 24, 2020. REUTERS/Amir Cohen/File Photo

TORONTO (Reuters) – Canadian and U.S. cannabis companies are facing a spike in already high costs of insurance to protect top executives from personal liability, following a slew of lawsuits by disgruntled investors alleging fraud and misinformation, with more such action expected.

Some of the biggest cannabis companies, including Medmen Enterprises, Canopy Growth, CannTrust Holdings, Aphria Inc and Columbia Care, have faced shareholder litigation, accusing leaders of false claims, failing to act in the interest of all shareholders and attempts to defraud investors.

The lawsuits are yet another sign of souring sentiment against an industry that has failed to deliver on promises of boundless growth. And the rising costs are another headwind for companies already shuttering operations and cutting jobs due to slower-than-expected demand.

“More frequently we’re seeing prospective investors and board members requiring (directors’ and officers’) coverage in place prior to engaging with a company in order to ensure adequate protection in the event of…litigation,” said Charles Grodecki, senior vice president at insurance brokerage AmWINS Brokerage of the Carolinas.

“With claims starting to roll in, we’re beginning to see higher entry-level premiums.”

Cannabis companies generated a lot of investor excitement in recent years as the drug was legalized for recreational use in Canada and 11 U.S. states as well as the District of Columbia. Marijuana is authorized for medical use in many more.

But investors have faced losses as well as coronavirus-driven market downturns, and they are increasingly likely to target companies and executives who have not delivered on big promises, like cannabis firms, said Ian Stewart, partner at law firm Wilson Elser.

That could drive rates and deductibles higher, with the industry already paying well above what non-cannabis companies pay for similar insurance products.

“We expect a flurry of cases holding directors personally liable,” Stewart said.

Avis Bulbulyan of cannabis consultancy Siva Enterprises, estimates a 50% spike in litigation.

A spokeswoman for Canopy declined to comment. Medmen, CannTrust, Aphria and Columbia Care did not respond to requests for comment.

The Horizons Marijuana Life Sciences Index ETF has lost 61% over the past year, while the S&P 500 index is up 6%.

RISING PREMIUMS

Entry-level premiums for directors & officers (D&O) insurance for public companies have more than doubled to $250,000 for $1 million cover over the past year or so, on top of as much as $1 million firms must pay before the coverage kicks in, known as retention, according to AmWINS.

Some insurers have also added exclusionary language specific to cannabis and have raised retention levels, leaving some companies unable to renew policies or forced to choose lower limits with inadequate coverage, said Katie Verry, vice president at broker CRC Insurance Services.

Most major insurers do not offer cannabis D&O policies because cannabis is not legal under U.S. federal law and the nascent industry has increased risks.

There are even fewer insurers now, said Kirk Miller, executive producer at cannabis risk-management firm Nine Point Strategies. Insurance market Lloyd’s of London and the insurance regulator of Bermuda have prohibited insurers from underwriting cannabis coverage in the United States.

“With both Lloyd’s and (insurers from) Bermuda pulling out of the U.S. cannabis market, coupled with the 25+ security class-action lawsuits over the last two-and-a-half years… underwriters’ appetite for cannabis is narrowing,” he said.

The heavy demand and a dearth of suppliers has kept prices extremely high.

To Read The Rest Of This Article By Shariq Khan and Nichola saminather on Reuters
Click Here

Published: July 08, 2020

The post Cannabis firms see jump in insurance costs to protect leaders as investors sue appeared first on L.A. Cannabis News.

Credit: Source link

Share160Tweet100SendShare28Pin36
Previous Post

Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 438 (NASDAQ: VFF) (CSE: NOVA) (CSE: LOVE) (OTCQB: MGWFF)

Next Post

Premium Cannabis Brand El Blunto Announces Collaboration with Josh D Farms on their Signature Cannabis Cigar Line

Related Posts

Washington, D.C. Mayor Signs Medical Pot Bill
News

Washington, D.C. Mayor Signs Medical Pot Bill

February 2, 2023
Republican Congressman Reintroduces Bill To Move Cannabis to Schedule III
News

Republican Congressman Reintroduces Bill To Move Cannabis to Schedule III

February 2, 2023
How to find the legal weed stores opening Feb. 6 in Missouri
News

How to find the legal weed stores opening Feb. 6 in Missouri

February 1, 2023
What are cordyceps mushrooms? Can they really turn their hosts into zombies?
News

What are cordyceps mushrooms? Can they really turn their hosts into zombies?

February 1, 2023
Load More
Next Post
Premium Cannabis Brand El Blunto Announces Collaboration with Josh D Farms on their Signature Cannabis Cigar Line

Premium Cannabis Brand El Blunto Announces Collaboration with Josh D Farms on their Signature Cannabis Cigar Line

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Updates

Switzerland Launches Pilot Program for Cannabis Sales

Switzerland Launches Pilot Program for Cannabis Sales

February 2, 2023
Republican Congressman Reintroduces Bill To Move Cannabis to Schedule III

Republican Congressman Reintroduces Bill To Move Cannabis to Schedule III

February 2, 2023
Washington, D.C. Mayor Signs Medical Pot Bill

Washington, D.C. Mayor Signs Medical Pot Bill

February 2, 2023
Are We Too Stoned To See an Impending Alien Invasion?

Are We Too Stoned To See an Impending Alien Invasion?

February 2, 2023
Trump says Harris ‘lied’ when questioned on cannabis (Newsletter: August 13, 2020)

Schumer hosts cannabis meeting with other lawmakers (Newsletter: February 2, 2023)

February 2, 2023
CBDBuzzz.com

This is an online news portal that aims to share latest news about "News, Culture, Science, Health, Shop" and much more stuff like that. Feel free to get in touch with us!

Recent News

Switzerland Launches Pilot Program for Cannabis Sales

Switzerland Launches Pilot Program for Cannabis Sales

February 2, 2023
Republican Congressman Reintroduces Bill To Move Cannabis to Schedule III

Republican Congressman Reintroduces Bill To Move Cannabis to Schedule III

February 2, 2023

Subscribe Now

Loading
  • Contact Us
  • Privacy Policy

© 2020 matans3.sg-host.com - All rights reserved!

No Result
View All Result
  • Home
  • News
  • Culture
  • Science
  • Health
  • Videos
  • Shop

© 2020 matans3.sg-host.com - All rights reserved!